Dapoxetine approved for treatment of premature ejaculation

Published: 2009-07-31 06:59:00

Updated: 2009-07-31 06:59:00

The Korea Food and Drug Administration said on June 28 it has given a green light to Priligy (dapoxetine) for the treatment of premature ejaculation (PE) in men, according to Janssen Korea.

Dapoxetine, an selective serotonin re-uptake inhibitor (SSRI) designed to treat PE, not approved as an a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK